Sabet, Z.; Vagiannis, D.; Budagaga, Y.; Zhang, Y.; Novotná, E.; Hanke, I.; Rozkoš, T.; Hofman, J.
Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study. Int. J. Mol. Sci. 2022, 23, 14338.
https://doi.org/10.3390/ijms232214338
AMA Style
Sabet Z, Vagiannis D, Budagaga Y, Zhang Y, Novotná E, Hanke I, Rozkoš T, Hofman J.
Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study. International Journal of Molecular Sciences. 2022; 23(22):14338.
https://doi.org/10.3390/ijms232214338
Chicago/Turabian Style
Sabet, Ziba, Dimitrios Vagiannis, Youssif Budagaga, Yu Zhang, Eva Novotná, Ivo Hanke, Tomáš Rozkoš, and Jakub Hofman.
2022. "Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study" International Journal of Molecular Sciences 23, no. 22: 14338.
https://doi.org/10.3390/ijms232214338
APA Style
Sabet, Z., Vagiannis, D., Budagaga, Y., Zhang, Y., Novotná, E., Hanke, I., Rozkoš, T., & Hofman, J.
(2022). Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study. International Journal of Molecular Sciences, 23(22), 14338.
https://doi.org/10.3390/ijms232214338